JP2002536989A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002536989A5 JP2002536989A5 JP2000601127A JP2000601127A JP2002536989A5 JP 2002536989 A5 JP2002536989 A5 JP 2002536989A5 JP 2000601127 A JP2000601127 A JP 2000601127A JP 2000601127 A JP2000601127 A JP 2000601127A JP 2002536989 A5 JP2002536989 A5 JP 2002536989A5
- Authority
- JP
- Japan
- Prior art keywords
- gpr54
- substance
- seq
- cell
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101001091205 Homo sapiens KiSS-1 receptor Proteins 0.000 description 24
- 102100034845 KiSS-1 receptor Human genes 0.000 description 24
- 239000000126 substance Substances 0.000 description 17
- 125000003275 alpha amino acid group Chemical group 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000000556 agonist Substances 0.000 description 5
- 239000005557 antagonist Substances 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003446 ligand Substances 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 102100036584 Galanin receptor type 2 Human genes 0.000 description 1
- 102100036588 Galanin receptor type 3 Human genes 0.000 description 1
- 101001072780 Homo sapiens Galanin receptor type 2 Proteins 0.000 description 1
- 101001072777 Homo sapiens Galanin receptor type 3 Proteins 0.000 description 1
- 101100447611 Rattus norvegicus Galr1 gene Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12165199P | 1999-02-24 | 1999-02-24 | |
| US60/121,651 | 1999-02-24 | ||
| PCT/US2000/004416 WO2000050563A2 (en) | 1999-02-24 | 2000-02-22 | G protein-coupled receptor resembling galanin receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002536989A JP2002536989A (ja) | 2002-11-05 |
| JP2002536989A5 true JP2002536989A5 (enExample) | 2007-04-12 |
Family
ID=22397998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000601127A Pending JP2002536989A (ja) | 1999-02-24 | 2000-02-22 | ガラニン受容体と類似したｇタンパク質共役受容体 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1157097A4 (enExample) |
| JP (1) | JP2002536989A (enExample) |
| CA (1) | CA2364988A1 (enExample) |
| WO (1) | WO2000050563A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4486187B2 (ja) | 1998-10-27 | 2010-06-23 | 武田薬品工業株式会社 | 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド |
| US20020077469A1 (en) * | 1999-03-10 | 2002-06-20 | Borowsky Beth E. | DNA encoding orphan SNORF11 receptor |
| EP1273658A4 (en) * | 2000-03-30 | 2004-08-11 | Takeda Chemical Industries Ltd | NEW PROTEIN, THEIR DNA AND METHOD FOR THE PRODUCTION THEREOF |
| WO2002059344A2 (en) * | 2000-12-18 | 2002-08-01 | Merck & Co., Inc. | Gpr54 g protein-coupled receptor |
| WO2002072816A1 (fr) * | 2001-02-26 | 2002-09-19 | Takeda Chemical Industries, Ltd. | Proteine de recepteur murin de type kiss-1 et adn correspondant |
| US20050014689A1 (en) * | 2001-10-02 | 2005-01-20 | Eiji Sugaru | Remedies for life style-related diseases or cibophobia and method of screening the same |
| JP2006521082A (ja) * | 2002-09-11 | 2006-09-21 | ジェネンテック・インコーポレーテッド | 免疫関連疾患の治療のための新規組成物と方法 |
| GB0304021D0 (en) * | 2003-02-21 | 2003-03-26 | Pfizer Ltd | Treatment of hypertension |
| AU2004234399A1 (en) * | 2003-04-28 | 2004-11-11 | Wyeth | Methods utilising G-protein coupled receptor 54 |
| WO2005040833A1 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Regulation of human metastin recognising receptors |
| EP1809619A1 (en) | 2004-10-21 | 2007-07-25 | Transtech Pharma, Inc. | Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| GB0719592D0 (en) * | 2007-10-08 | 2007-11-14 | Medical Res Council | Compound, use and method |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9602822D0 (sv) * | 1996-07-19 | 1996-07-19 | Astra Pharma Inc | New receptor |
| JP4486187B2 (ja) * | 1998-10-27 | 2010-06-23 | 武田薬品工業株式会社 | 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド |
-
2000
- 2000-02-22 JP JP2000601127A patent/JP2002536989A/ja active Pending
- 2000-02-22 CA CA002364988A patent/CA2364988A1/en not_active Abandoned
- 2000-02-22 WO PCT/US2000/004416 patent/WO2000050563A2/en not_active Ceased
- 2000-02-22 EP EP00921344A patent/EP1157097A4/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002536989A5 (enExample) | ||
| US10962539B2 (en) | Interferon-λ4 (IFNL-4) protein, related nucleic acid molecules, and uses thereof | |
| CA2299624A1 (en) | Mammalian cytokine receptor - 11 | |
| JP2003510037A5 (enExample) | ||
| Kaldy et al. | Identification of RNA‐binding surfaces in iron regulatory protein‐1 | |
| CA2343979A1 (en) | Human interleukin-b50, therapeutic uses | |
| JP2005518212A5 (enExample) | ||
| CA2450581A1 (en) | Cardiovascular safety assay | |
| Schöneberg et al. | Molecular aspects of vasopressin receptor function | |
| CA2186573A1 (en) | Sh2-containing inositol-phosphatase | |
| Koli et al. | Novel non-TGF-β-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-β deposition | |
| CA2390659A1 (en) | Ny-eso-1 peptide derivatives, and uses thereof | |
| JP2006502738A5 (enExample) | ||
| Traish et al. | Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer | |
| JP2003530821A5 (enExample) | ||
| Almenoff et al. | Induction of heat-stable enterotoxin receptor activity by a human Alu repeat | |
| JP2005516604A5 (enExample) | ||
| JP2002516658A5 (enExample) | ||
| JP2005528894A5 (enExample) | ||
| JP2004500055A5 (enExample) | ||
| JP2005507651A5 (enExample) | ||
| US20210382070A1 (en) | Diagnostic biomarkers for shrimp allergy | |
| JP2002529075A5 (enExample) | ||
| WO2005080426A2 (en) | Protein ligands for nkg2d and ul16 receptors and uses thereof | |
| Eldin et al. | Expression of human β-myosin heavy chain fragments in Escherichia coli; localization of actin interfaces on cardiac myosin |